CN Patent

CN102970992A — 四环素组合物

Assigned to Melinda Treatment Co ltd · Expires 2013-03-13 · 13y expired

What this patent protects

本发明涉及组合物、药物组合物及其制备方法，所述组合物、药物组合物包含稳定性和溶解度提高的四环素。一些实施方案包括四环素和过量的二价或三价阳离子。

USPTO Abstract

本发明涉及组合物、药物组合物及其制备方法，所述组合物、药物组合物包含稳定性和溶解度提高的四环素。一些实施方案包括四环素和过量的二价或三价阳离子。

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN102970992A
Jurisdiction: CN
Classification: —
Expires: 2013-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Melinda Treatment Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.